The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InIn a move reflecting active exit strategies within the healthcare sector, Blackstone and TPG are reportedly exploring the sale of Hologic's surgical unit. According to reports, the private equity firms are seeking a valuation exceeding $4 billion for the specialized business. The proposed divestiture is primarily aimed at paying down debt and returning cash to investors following a major leveraged buyout executed last year.
This trend emerges as the private equity industry faces increasing pressure to generate liquidity, with healthcare exit volumes reaching significant levels recently. Compared to peers, market data shows firms like KKR and Carlyle Group have also accelerated non-core asset sales to strengthen balance sheets. Per market data, Blackstone's BX stock is currently trading at levels that reflect investor optimism regarding asset monetization plans.
Traders should monitor BX shares, which stood at $118.62 at close July 08, 2026, for any price reaction to official deal confirmation. With no immediate sector-specific catalysts in the upcoming economic calendar, focus remains on final valuation details and potential buyers, noting the stock reached a recent low of $116.8 at close July 08, 2026, serving as a technical support level for observers.